Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05144516 · ClinicalTrials.gov registry record · NA

Cancer and Mild Cognitive Impairment Dyadic Intervention

A NA study of Cancer and Cognitive Impairment, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT05144516 is a NA study of Cancer and Cognitive Impairment that is actively recruiting participants, run by Duke University. The registered enrollment target is 80 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05144516, a NA study of Cancer and Cognitive Impairment, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of the dyad has cancer and mild memory difficulties and/or concerns. Participant and their spouse or participant and their family caregiver will have six, 60-minute video-conference sessions which will be scheduled at their convenience. The investigator will loan participants a tablet computer (iPad) to use for videoconferencing and train the participant in its use. Participant and their spouse or participant and their family caregiver will complete three assessments - one before starting the sessions, one after the sixth session, and one after 1 month. Each assessment will include surveys, which the participant will complete separately from their spouse or family caregiver. For most people, it will take upwards of 2 - 4 months to complete this study

Interventions

  • BEHAVIORAL Behavioral: COPE +

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2024-09-30
Est. Completion 2027-08-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT05144516

The ClinicalTrials.gov registry entry for NCT05144516 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Behavioral: COPE + is the first listed.

NCT05144516 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05144516 about?

NCT05144516 is a clinical study titled "Cancer and Mild Cognitive Impairment Dyadic Intervention". The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of the dyad has cancer and mild memory difficulties and/or concerns. Participant and their spouse or part...

What is the current status of trial NCT05144516?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2024-09-30. Estimated completion is 2027-08-31.

What conditions does trial NCT05144516 study?

This clinical trial studies the following conditions: Cancer, Cognitive Impairment.

What interventions are being tested in trial NCT05144516?

The interventions under investigation include: Behavioral: COPE + (BEHAVIORAL).

Who is sponsoring clinical trial NCT05144516?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05144516 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.